Elocom ointment 0.1%, 30g — Made in Belgium — Free Delivery

Mometasone furoate is a synthetic corticosteroids for topical use. has anti-inflammatory, antipruritic and antiexudative effects.

Pharmacokinetics. The results of the study showed that systemic absorption after topical application of mometasone furoate 0.1% is minimal; about 0.4% of the dose is excreted from the body within 72 hours after application. It was practically impossible to establish the nature of the metabolites due to the small amount in the blood plasma and excrement.

Inflammation and itching in dermatoses sensitive to corticosteroid therapy, including psoriasis (except for common plaque psoriasis) and atopic dermatitis, in adults and children over the age of 2 years.

Elokom lotion is also used to treat dermatoses on the surface of the scalp.

Ointment or cream is applied in a thin layer to the affected skin once a day. the duration of treatment depends on the severity, course of the disease and is determined individually.

The use of topical corticosteroids in children and on the face should be limited to the minimum amount compared to effective therapeutic regimens, while the duration of treatment should not exceed 5 days.

A few drops of lotion are applied to the affected skin once a day and rubbed gently and thoroughly until completely absorbed.

Rosacea, acne vulgaris, skin atrophy, perioral dermatitis, perianal and genital itching, rash due to wearing diapers, bacterial (eg impetigo, pyoderma), viral (eg herpes zoster, herpes zoster and chickenpox, simple warts, genital warts, contagiosus), contagiosum parasitic and fungal (for example, dermatophytosis or caused by candida) infections, tuberculosis, syphilis or post-vaccination reactions. the preparation should not be applied to wounds or ulcerated skin. the preparation  is contraindicated in patients with hypersensitivity to any of the components of the preparation or other corticosteroids.

Below are the adverse reactions reported in connection with the use of the preparation, by organ system and frequency: very often (≥1 / 10); often (≥1 / 100, 1/10); infrequently (≥1 / 1000, 1/100); rarely (≥1 / 10,000, 1/1,000); very rare (1/10 000); unknown (cannot be estimated from the available data).

Infections and invasions: very rarely - folliculitis; unknown - infections, boils.

From the side of the nervous system: very rarely - a burning sensation; unknown - paresthesia.

On the part of the skin and subcutaneous tissue: very rarely - itching; unknown - contact dermatitis, skin hypopigmentation, hypertrichosis, atrophic stripes on the skin, acne-like dermatitis, skin atrophy.

General disorders and reactions at the site of application: unknown - pain at the site of application, reactions at the site of application.

Propylene glycol, which is part of the preparation, can cause skin irritation. Local adverse reactions, which have rarely been reported in connection with the use of topical dermatological corticosteroids, include: dryness and irritation of the skin, dermatitis, perioral dermatitis, skin maceration, striae, prickly heat and telangiectasias, papular, pustular eruptions, and tingling sensations.

If irritation or increased sensitivity is noted during the use of the preparation, treatment should be discontinued and appropriate therapy prescribed.

If a concomitant skin infection develops, an appropriate antifungal or antibacterial agent should be used. If a positive effect cannot be achieved for a short time, the preparation should be discontinued until the signs of infection are eliminated.